Literature DB >> 12324929

Dosing darbepoetin alfa.

Allen R Nissenson.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12324929     DOI: 10.1053/ajkd.2002.36566

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

1.  Equivalent Doses Matter, Rather Than Types.

Authors:  Norio Hanafusa; Ken Tsuchiya
Journal:  J Am Soc Nephrol       Date:  2019-08-16       Impact factor: 10.121

Review 2.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability.

Authors:  Javier Arrieta; Iñigo Moina; José Molina; Isabel Gallardo; María Luisa Muñiz; Carmen Robledo; Oscar García; Fernando Vidaur; Rosa Inés Muñoz; Izaskun Iribar; Román Aguirre; Antonio Maza
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-09

Review 4.  Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Authors:  Suetonia C Palmer; Valeria Saglimbene; Dimitris Mavridis; Georgia Salanti; Jonathan C Craig; Marcello Tonelli; Natasha Wiebe; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-12-08

Review 5.  Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.

Authors:  Deirdre Hahn; June D Cody; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2014-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.